Functional characterization of splicing and ligand-binding domain variants in the LDL receptor

Abifadel, 2003, Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, Nat Genet, 34, 154, 10.1038/ng1161

Adzhubei, 2010, A method and server for predicting damaging missense mutations, Nat Methods, 7, 248, 10.1038/nmeth0410-248

Alonso, 2009, Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform, Clin Biochem, 42, 899, 10.1016/j.clinbiochem.2009.01.017

Alonso, 2008, Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors, Atherosclerosis, 200, 315, 10.1016/j.atherosclerosis.2007.12.024

Amsellem, 2002, Intronic mutations outside of Alu-repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia, Hum Genet, 111, 501, 10.1007/s00439-002-0813-4

Beglova, 2004, Cooperation between fixed and low pH-inducible interfaces controls lipoprotein release by the LDL receptor, Mol Cell, 16, 281, 10.1016/j.molcel.2004.09.038

Blanchette, 2004, Aligning multiple genomic sequences with the threaded blockset aligner, Genome Res, 14, 708, 10.1101/gr.1933104

Bourbon, 2008, Familial hypercholesterolaemia in Portugal, Atherosclerosis, 196, 633, 10.1016/j.atherosclerosis.2007.07.019

Bourbon, 2009, Genetic diagnosis of familial hypercholesterolaemia: the importance of functional analysis of potential splice-site mutations, J Med Genet, 46, 352, 10.1136/jmg.2007.057000

Bunn, 2002, Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort, Hum Mutat, 19, 311-315, 10.1002/humu.9021

Buratti, 2007, Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization, Nucleic Acids Res, 35, 4250, 10.1093/nar/gkm402

Burset, 2000, Analysis of canonical and non-canonical splice sites in mammalian genomes, Nucleic Acids Res, 28, 4364, 10.1093/nar/28.21.4364

Cameron, 2009, Splice-site mutation c.313+1, G>A in intron 3 of the LDL receptor gene results in transcripts with skipping of exon 3 and inclusion of intron 3, Clin Chim Acta, 403, 131, 10.1016/j.cca.2009.02.001

Carmel, 2004, Comparative analysis detects dependencies among the 5' splice-site positions, RNA, 10, 828, 10.1261/rna.5196404

Davis, 1986, The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors, Cell, 45, 15, 10.1016/0092-8674(86)90533-7

Defesche, 2000, Lipids and vascular disease, 65

Desmet, 2009, Human Splicing Finder: an online bioinformatics tool to predict splicing signals, Nucleic Acid Res, 37, e67, 10.1093/nar/gkp215

Desmet, 2010, Research advances in nucleic acid research

Ebhardt, 1999, Mutation analysis in 46 German families with familial hypercholesterolemia: identification of 8 new mutations, Hum Mutat, 13, 257-262, 10.1002/(SICI)1098-1004(1999)13:3<257::AID-HUMU14>3.0.CO;2-D

Esser, 1988, Mutational analysis of the ligand binding domain of the low density lipoprotein receptor, J Biol Chem, 263, 13282, 10.1016/S0021-9258(18)37702-0

Fass, 1997, Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module, Nature, 388, 691, 10.1038/41798

Fouchier, 2001, The molecular basis of familial hypercholesterolemia in the Netherlands, Hum Genet, 109, 602, 10.1007/s00439-001-0628-8

Fouchier, 2005, Update of the molecular basis of familial hypercholesterolemia in the Netherlands, Hum Mutat, 26, 550, 10.1002/humu.20256

Grantham, 1974, Amino acid difference formula to help explain protein evolution, Science, 185, 862, 10.1126/science.185.4154.862

Goldstein, 1985, Receptor-mediated endocytosis: concepts emerging from the LDL receptor system, Annu Rev Cell Biol, 1, 1, 10.1146/annurev.cb.01.110185.000245

Goldstein, 2001, The metabolic basis of inherited disease., 2863

Hicks, 2011, Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed, Hum Mutat, 32, 661, 10.1002/humu.21490

Hobbs, 1992, Molecular genetics of the LDL receptor gene in familial hypercholesterolemia, Hum Mutat, 1, 445, 10.1002/humu.1380010602

Hobbs, 1988, Multiple crm-mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions, J Clin Invest, 81, 909, 10.1172/JCI113402

Holla, 2009b, Nonsense-mediated decay of human LDL receptor mRNA, Scand J Clin Lab Invest, 69, 409, 10.1080/00365510802707163

Holla, 2009a, Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: comparison of wet-lab and bioinformatics analyses, Mol Genet Metab, 96, 245, 10.1016/j.ymgme.2008.12.014

Houdayer, 2008, Evaluation of in silico splice tools for decision-making in molecular diagnosis, Hum Mutat, 29, 975, 10.1002/humu.20765

Jarauta, 2010, Carotid intima-media thickness in subjects with no cardiovascular risk factors, Rev Esp Cardiol, 63, 97, 10.1016/S0300-8932(10)70014-2

Junyent, 2008, Femoral atherosclerosis in heterozygous familial hypercholesterolemia: influence of the genetic defect, Arterioscler Thromb Vasc Biol, 28, 580, 10.1161/ATVBAHA.107.153841

Krawczak, 2007, Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing, Hum Mutat, 28, 150, 10.1002/humu.20400

Lehrman, 1985, Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain, Cell, 41, 735, 10.1016/S0092-8674(85)80054-4

Leigh, 2008, Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database, Ann Hum Genet, 72, 485, 10.1111/j.1469-1809.2008.00436.x

Liguori, 2001, LDL receptor cDNA sequence analysis in familial hypercholesterolemia patients: 5 novel mutations with high prevalence in families originating from southern Italy, Hum Mutat, 17, 433-436, 10.1002/humu.1122

Marduel, 2010, Molecular spectrum of autosomal dominant hypercholesterolemia in France, Hum Mutat, 31, E1811, 10.1002/humu.21348

Mathe, 2006, Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods, Nucleic Acids Res, 34, 1317, 10.1093/nar/gkj518

Mozas, 2004, Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR, Hum Mutat, 24, 187-199, 10.1002/humu.9264

Mozas, 2000, Mutation analysis in 36 unrelated Spanish subjects with familial hypercholesterolemia: identification of 3 novel mutations in the LDL receptor gene, Hum Mutat, 15, 483, 10.1002/(SICI)1098-1004(200005)15:5<483::AID-HUMU19>3.0.CO;2-Q

Ng, 2003, SIFT: predicting amino acid changes that affect protein function, Nucleic Acids Res, 31, 3812, 10.1093/nar/gkg509

Nguyen, 2006, Binding characteristics of a panel of monoclonal antibodies against the ligand binding domain of the human LDLr, J Lipid Res, 47, 1399, 10.1194/jlr.M600130-JLR200

North, 2000, Solution structure of the sixth LDL-A module of the LDL receptor, Biochemistry, 39, 2564, 10.1021/bi992087a

Pena, 2010, Calcium as a crucial cofactor for low density lipoprotein receptor folding in the endoplasmic reticulum, J Biol Chem., 285, 8656, 10.1074/jbc.M110.105718

Pullinger, 1995, Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity, J Clin Invest, 95, 1225, 10.1172/JCI117772

Ranheim, 2006, Model system for phenotypic characterization of sequence variations in the LDL receptor gene, Clin Chem, 52, 1469, 10.1373/clinchem.2006.068627

Reese, 1997, Improved splice site detection in genie, J Comp Biol, 4, 311, 10.1089/cmb.1997.4.311

Russell, 1989, Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins, J Biol Chem, 264, 21682, 10.1016/S0021-9258(20)88240-4

Richards, 2008, ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007, Genet Med, 10, 294, 10.1097/GIM.0b013e31816b5cae

Tada, 2009, A novel method for determining functional LDL receptor activity in familial hypercholesterolemia: application of the CD3/CD28 assay in lymphocytes, Clin Chim Acta, 400, 42, 10.1016/j.cca.2008.10.010

Tavtigian, 2006, Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral, J Med Genet, 43, 295, 10.1136/jmg.2005.033878

Tejedor, 2005, Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia, Clin Chem, 51, 1137, 10.1373/clinchem.2004.045203

Tejedor, 2006, Comparison of DNA array platform vs DNA sequencing as genetic diagnosis tools for familial hypercholesterolemia, Clin Chem, 52, 1971, 10.1373/clinchem.2006.073957

Tosi, 2007, Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic, Atherosclerosis, 194, 102, 10.1016/j.atherosclerosis.2006.10.003

Tveten, 2006, Analysis of alternatively spliced isoforms of human LDL receptor mRNA, Clin Chim Acta, 373, 151, 10.1016/j.cca.2006.05.031

Umans-Eckenhausen, 2002, Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population, Circulation, 106, 3031, 10.1161/01.CIR.0000041253.61683.08

Van Driel, 1989, Stoichiometric binding of low density lipoprotein (LDL) and monoclonal antibodies to LDL receptors in a solid phase assay, J Biol Chem, 264, 9533, 10.1016/S0021-9258(18)60564-2

Wang, 2005, Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia, J Lipid Res, 46, 366, 10.1194/jlr.D400030-JLR200

Yeo, 2004, Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals, J Comput Biol, 11, 377, 10.1089/1066527041410418

Zhang, 1998, Statistical features of human exons and their flanking regions, Hum Mol Genet, 7, 919, 10.1093/hmg/7.5.919